IgA nephropathy, susceptibility to, 1
MONDO:0008072Also known as: IGAN1, IgA nephropathy, susceptibility to, 1, Igan, berger disease, glomerulonephritis, IgA, nephritis, IgA type
16 clinical trials for this condition and its sub-types.
Follow this condition to get notified about new trialsBroader categories
-
New drug OMS721 tested for rare kidney conditions
Disease control Stopped earlyThis study tested a drug called OMS721 in 31 people with certain kidney diseases, including IgA nephropathy and lupus nephritis. The main goal was to check if the drug is safe and if it reduces protein in the urine, a sign of kidney damage. The study was stopped early, so results…
Phase 2 • Sponsor: Omeros Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Kidney disease drug trial halted midway: what happened?
Disease control Stopped earlyThis study tested a drug called ALXN2050 in people with kidney inflammation caused by lupus (lupus nephritis) or IgA nephropathy. The goal was to see if it could reduce protein in the urine, a sign of kidney damage. About 100 adults were planned to take the drug or a placebo alon…
Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC